Acute Headache Treatment

Published Online: Thursday, October 20, 2011
Robert Kaniecki, MD, director of the Headache Center and chief of the Headache Division at the University of Pittsburgh, explores promising new therapies for acute migraine in this podcast. Dr. Kaniecki will review key findings from the past 5 years, focusing specifically on new ways of administering drugs and new ways of using old drugs.

To listen, click here.
Latest Articles
Skipping a flu shot may put patients at greater risk for flu-related pneumonia.
This weekly video program highlights the latest in pharmacy news, product news, and more.
Mylan has launched a generic version of Teva Pharmaceuticals’ Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses.
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
Latest Issues